Cargando…
Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
Lung microbiome ecosystem homeostasis in idiopathic pulmonary fibrosis (IPF) remains uncharacterized. The aims of this study were to identify unique microbial signatures of the lung microbiome and analyze microbial gene function in IPF patients. DNA isolated from BALF samples was obtained for high-t...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536613/ https://www.ncbi.nlm.nih.gov/pubmed/31165050 http://dx.doi.org/10.3389/fcimb.2019.00149 |
_version_ | 1783421788416376832 |
---|---|
author | Tong, Xunliang Su, Fei Xu, Xiaomao Xu, Hongtao Yang, Ting Xu, Qixia Dai, Huaping Huang, Kewu Zou, Lihui Zhang, Wenna Pei, Surui Xiao, Fei Li, Yanming Wang, Chen |
author_facet | Tong, Xunliang Su, Fei Xu, Xiaomao Xu, Hongtao Yang, Ting Xu, Qixia Dai, Huaping Huang, Kewu Zou, Lihui Zhang, Wenna Pei, Surui Xiao, Fei Li, Yanming Wang, Chen |
author_sort | Tong, Xunliang |
collection | PubMed |
description | Lung microbiome ecosystem homeostasis in idiopathic pulmonary fibrosis (IPF) remains uncharacterized. The aims of this study were to identify unique microbial signatures of the lung microbiome and analyze microbial gene function in IPF patients. DNA isolated from BALF samples was obtained for high-throughput gene sequencing. Microbial metagenomic data were used for principal component analysis (PCA) and analyzed at different taxonomic levels. Shotgun metagenomic data were annotated using the KEGG database and were analyzed for functional and metabolic pathways. In this study, 17 IPF patients and 38 healthy subjects (smokers and non-smokers) were recruited. For the PCA, the first and the second principal component explained 16.3 and 13.4% of the overall variability, respectively. The β diversity of microbiome was reduced in the IPF group. Signature of IPF's microbes was enriched of Streptococcus, Pseudobutyrivibrio, and Anaerorhabdus. The translocation of lung microbiome was shown that 32.84% of them were from oral. After analysis of gene function, ABC transporter systems, biofilm formation, and two-component regulatory system were enriched in IPF patients' microbiome. Here we shown the microbiology characteristics in IPF patients. The microbiome may participate in altering internal conditions and involving in generating antibiotic resistance in IPF patients. |
format | Online Article Text |
id | pubmed-6536613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65366132019-06-04 Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients Tong, Xunliang Su, Fei Xu, Xiaomao Xu, Hongtao Yang, Ting Xu, Qixia Dai, Huaping Huang, Kewu Zou, Lihui Zhang, Wenna Pei, Surui Xiao, Fei Li, Yanming Wang, Chen Front Cell Infect Microbiol Cellular and Infection Microbiology Lung microbiome ecosystem homeostasis in idiopathic pulmonary fibrosis (IPF) remains uncharacterized. The aims of this study were to identify unique microbial signatures of the lung microbiome and analyze microbial gene function in IPF patients. DNA isolated from BALF samples was obtained for high-throughput gene sequencing. Microbial metagenomic data were used for principal component analysis (PCA) and analyzed at different taxonomic levels. Shotgun metagenomic data were annotated using the KEGG database and were analyzed for functional and metabolic pathways. In this study, 17 IPF patients and 38 healthy subjects (smokers and non-smokers) were recruited. For the PCA, the first and the second principal component explained 16.3 and 13.4% of the overall variability, respectively. The β diversity of microbiome was reduced in the IPF group. Signature of IPF's microbes was enriched of Streptococcus, Pseudobutyrivibrio, and Anaerorhabdus. The translocation of lung microbiome was shown that 32.84% of them were from oral. After analysis of gene function, ABC transporter systems, biofilm formation, and two-component regulatory system were enriched in IPF patients' microbiome. Here we shown the microbiology characteristics in IPF patients. The microbiome may participate in altering internal conditions and involving in generating antibiotic resistance in IPF patients. Frontiers Media S.A. 2019-05-21 /pmc/articles/PMC6536613/ /pubmed/31165050 http://dx.doi.org/10.3389/fcimb.2019.00149 Text en Copyright © 2019 Tong, Su, Xu, Xu, Yang, Xu, Dai, Huang, Zou, Zhang, Pei, Xiao, Li and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Tong, Xunliang Su, Fei Xu, Xiaomao Xu, Hongtao Yang, Ting Xu, Qixia Dai, Huaping Huang, Kewu Zou, Lihui Zhang, Wenna Pei, Surui Xiao, Fei Li, Yanming Wang, Chen Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients |
title | Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients |
title_full | Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients |
title_fullStr | Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients |
title_full_unstemmed | Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients |
title_short | Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients |
title_sort | alterations to the lung microbiome in idiopathic pulmonary fibrosis patients |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536613/ https://www.ncbi.nlm.nih.gov/pubmed/31165050 http://dx.doi.org/10.3389/fcimb.2019.00149 |
work_keys_str_mv | AT tongxunliang alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT sufei alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT xuxiaomao alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT xuhongtao alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT yangting alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT xuqixia alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT daihuaping alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT huangkewu alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT zoulihui alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT zhangwenna alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT peisurui alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT xiaofei alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT liyanming alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients AT wangchen alterationstothelungmicrobiomeinidiopathicpulmonaryfibrosispatients |